Suraksha Diagnostic

Suraksha Diagnostic

301.90
-8.20
(-2.64%)
hide
Key Fundamentals
Add Ratio
Market Cap
1,615.00 Cr
EPS
5.97
PE Ratio
52.01
Dividend Yield
0.00 %
52 Week High
449.00
52 Week Low
231.00
PB Ratio
7.03
Debt to Equity
0.46
Forecast For
Actual

Company News

View All News
Caret
neutral
Suraksha Diagnostic Q2 FY26 Results: Revenue Growth Continues Despite Weather Challenges3 days ago
Suraksha Diagnostic reported 16.9% revenue growth to INR 795.8 million in Q2 FY26, though EBITDA margin dropped to 31.7% from weather-related disruptions and new center investments. The company launched Suraksha Genomics for advanced genetic testing and maintains guidance of 15% revenue growth for FY26 with EBITDA margins of 33-34%, while expanding its network to 63 centers.
positive
Suraksha Diagnostic Limited announced its quarterly results for the quarter and six months ended September 30, 2025. The company reported consolidated revenue from operations of Rs 7,258.63 lakhs for the quarter compared to Rs 6,675.35 lakhs in the previous quarter. Profit after tax surged to Rs 892.37 lakhs from Rs 95.48 lakhs in the prior quarter. For the six-month period, consolidated revenue reached Rs 12,748.50 lakhs with profit after tax of Rs 1,828.28 lakhs. The company completed acquisition of Fetomat Wellness Private Limited on April 8, 2025, acquiring 63% equity stake for Rs 3,73,423 equity shares, making it a subsidiary. Basic earnings per share improved to Rs 1.72 for the quarter from Rs 0.18 in the previous quarter. The Board meeting was held on November 10, 2025, where these unaudited financial results were approved.
positive
Suraksha Diagnostics achieved 17% year-over-year revenue growth with 63 operational centers. The company launched 'Suraksha Genomics' to enter the molecular testing market. Management expects margin improvement as 21 new centers reach maturity. The company is focusing on an asset-light business model and scale efficiency for sustainable profit growth in India's diagnostics sector.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,158.30
#1 26,416.10
48.94
#1 2,554.80
11.28
#1 492
16.36
52.08
1,039.40
10,893.00
71.60
699.70
23.06
144
2.85
57.88
1,982.30
10,210.20
64.37
1,346.30
10.64
146
13.28
50.35
1,552.80
8,288.30
65.54
702.20
20.80
91
81.06
73.52
826.80
2,615.20
30.88
742.70
16.70
78
22.45
56.60
301.90
#6 1,615.00
#6 52.01
#7 255.90
#6 15.11
#7 31
#10 -13.73
40.22
1,326.35
1,194.60
24.36
111.60
28.72
48
0.67
44.14
300.20
909.00
#1 -6.10
1,170.80
-18.47
-134
90.05
51.72
440.50
819.90
30.87
147.80
#1 134.60
19
#1 760.87
72.80
142.90
97.60
65.44
41.80
13.28
2
100.00
42.21
Growth Rate
Revenue Growth
15.11 %
Net Income Growth
34.20 %
Cash Flow Change
4.76 %
ROE
14.18 %
ROCE
10.95 %
EBITDA Margin (Avg.)
0.39 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
53
61
53
56
62
68
60
66
74
80
Expenses
37
39
37
37
40
44
41
46
49
55
EBITDA
16
21
16
20
22
25
19
20
25
25
Operating Profit %
28 %
35 %
30 %
34 %
34 %
35 %
31 %
29 %
33 %
31 %
Depreciation
8
8
8
8
9
9
9
9
10
10
Interest
2
3
2
2
2
2
2
2
3
3
Profit Before Tax
5
11
6
9
11
14
8
9
13
12
Tax
1
3
2
3
3
4
2
2
3
3
Net Profit
4
8
5
6
8
10
6
7
9
9
EPS in ₹
1.17
2.44
0.87
1.22
1.49
1.94
1.18
1.42
1.80
1.73

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
171
0
281
300
334
Fixed Assets
119
0
195
212
223
Current Assets
27
0
68
72
47
Capital Work in Progress
0
0
2
1
11
Investments
5
0
0
0
1
Other Assets
47
0
84
87
99
Total Liabilities
171
0
281
300
334
Current Liabilities
25
0
38
39
43
Non Current Liabilities
20
0
87
82
81
Total Equity
126
0
156
179
210
Reserve & Surplus
118
0
147
171
201
Share Capital
9
0
9
9
10

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-1
-0
-1
0
-0
Investing Activities
-20
-28
-44
-21
-35
-40
Operating Activities
31
24
42
44
61
63
Financing Activities
-10
3
1
-24
-25
-24

Share Holding

% Holding
Jul 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
72.41 %
61.06 %
48.78 %
48.78 %
48.88 %
48.98 %
FIIs
0.00 %
0.00 %
15.39 %
14.46 %
13.95 %
13.72 %
DIIs
0.00 %
0.00 %
20.44 %
22.05 %
22.37 %
21.98 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.08 %
13.52 %
13.08 %
12.96 %
Others
27.59 %
38.94 %
1.31 %
1.19 %
1.71 %
2.36 %
No of Share Holders
10
10
10
87,275
79,670
75,304

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Dec 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Dec 2024 411.35 408.00
08 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Feb 2025 311.80 347.15
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 314.65 326.95
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 304.80 290.45
05 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Sept 2025 326.95 302.70
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 317.80 319.40

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication6 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release7 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation7 days ago
Financial Results Of The Company For The Quarter And Six Months Ended 30 September 20257 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Monday 10 November 20257 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 03, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Closure of Trading WindowSep 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 08, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Clarification On AGM ResolutionSep 04, 2025
Weblink Letter To Shareholders As Per Regulation 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 14, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 08, 2025
Intimation For Grant Of Employee Stock Options Under SURAKSHA EMPLOYEE STOCK OPTION SCHEME 2024 (ESOP 2024/Scheme)Aug 08, 2025
Unaudited (Standalone And Consolidated) Financial Results For The Quarter And Three Months Ended 30 June 2025Aug 08, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Friday 08 August 2025Aug 08, 2025
Reg. 34 (1) Annual Report.Aug 07, 2025
Notice Of The 20Th Annual General Meeting (AGM) Of The Company To Be Held On Friday 05 September 2025Aug 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 05, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 25, 2025
Closure of Trading WindowJun 20, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 20, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 20, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 19, 2025

Technical Indicators

RSI(14)
Neutral
47.54
ATR(14)
Less Volatile
9.06
STOCH(9,6)
Neutral
31.54
STOCH RSI(14)
Oversold
2.45
MACD(12,26)
Bearish
-1.29
ADX(14)
Weak Trend
21.61
UO(9)
Bearish
54.97
ROC(12)
Downtrend And Accelerating
-3.95
WillR(14)
Neutral
-77.46